Identification of a Druggable Pathway Controlling Glioblastoma Invasiveness.

[1]  D. Alonso,et al.  CIGB-300, an anti-CK2 peptide, inhibits angiogenesis, tumor cell invasion and metastasis in lung cancer models. , 2017, Lung cancer.

[2]  Daniel I. S. Rosenbloom,et al.  Spatiotemporal genomic architecture informs precision oncology in glioblastoma , 2017, Nature Genetics.

[3]  A. Hjelmeland,et al.  Protein kinase CK2 is important for the function of glioblastoma brain tumor initiating cells , 2017, Journal of Neuro-Oncology.

[4]  Mårten Fryknäs,et al.  Clonal Variation in Drug and Radiation Response among Glioma-Initiating Cells Is Linked to Proneural-Mesenchymal Transition. , 2016, Cell reports.

[5]  David R. Jones,et al.  CK2α' Drives Lung Cancer Metastasis by Targeting BRMS1 Nuclear Export and Degradation. , 2016, Cancer research.

[6]  K. Marcelain,et al.  Colon cancer cell invasion is promoted by protein kinase CK2 through increase of endothelin-converting enzyme-1c protein stability , 2015, Oncotarget.

[7]  Voichita D. Marinescu,et al.  The Human Glioblastoma Cell Culture Resource: Validated Cell Models Representing All Molecular Subtypes , 2015, EBioMedicine.

[8]  Mingzhou Chen,et al.  Casein Kinase II Controls TBK1/IRF3 Activation in IFN Response against Viral Infection , 2015, The Journal of Immunology.

[9]  R. Derynck,et al.  Innate antiviral host defense attenuates TGF-β function through IRF3-mediated suppression of Smad signaling. , 2014, Molecular cell.

[10]  X. Tian,et al.  Stable knockdown of protein kinase CK2-alpha (CK2α) inhibits migration and invasion and induces inactivation of hedgehog signaling pathway in hepatocellular carcinoma Hep G2 cells. , 2014, Acta histochemica.

[11]  K. Bhat,et al.  TGF-β is an inducer of ZEB1-dependent mesenchymal transdifferentiation in glioblastoma that is associated with tumor invasion , 2014, Cell Death and Disease.

[12]  S. Cheshier,et al.  Casein Kinase 2α Regulates Glioblastoma Brain Tumor Initiating Cell Growth through the β-Catenin Pathway , 2014, Oncogene.

[13]  Simon Kasif,et al.  Reconstructing and Reprogramming the Tumor-Propagating Potential of Glioblastoma Stem-like Cells , 2014, Cell.

[14]  Stephen L. Brown,et al.  Subcurative radiation significantly increases cell proliferation, invasion, and migration of primary glioblastoma multiforme in vivo , 2014, Chinese journal of cancer.

[15]  C. Miller,et al.  Cooperativity between MAPK and PI3K signaling activation is required for glioblastoma pathogenesis. , 2013, Neuro-oncology.

[16]  M. Bredel,et al.  Targeting Protein Kinase CK2 Suppresses Prosurvival Signaling Pathways and Growth of Glioblastoma , 2013, Clinical Cancer Research.

[17]  Sunhee C. Lee,et al.  Interferon regulatory factor 3 alters glioma inflammatory and invasive properties , 2013, Journal of Neuro-Oncology.

[18]  Kevin Camphausen,et al.  Astrocytes Enhance the Invasion Potential of Glioblastoma Stem-Like Cells , 2013, PloS one.

[19]  Paul Bertone,et al.  Digital transcriptome profiling of normal and glioblastoma-derived neural stem cells identifies genes associated with patient survival , 2012, Genome Medicine.

[20]  E. Seki,et al.  Toll-Like Receptors in Liver Fibrosis: Cellular Crosstalk and Mechanisms , 2012, Front. Physio..

[21]  Pengfei Lu,et al.  The extracellular matrix: A dynamic niche in cancer progression , 2012, The Journal of cell biology.

[22]  Yanghua Xiao,et al.  Integrated analysis of mutations, miRNA and mRNA expression in glioblastoma , 2010, BMC Systems Biology.

[23]  Andrew P. Stubbs,et al.  Abstract 808: Intrinsic gene expression profiles of gliomas are a better predictor of survival than histology , 2010 .

[24]  S. Gabriel,et al.  Integrated genomic analysis identifies clinically relevant subtypes of glioblastoma characterized by abnormalities in PDGFRA, IDH1, EGFR, and NF1. , 2010, Cancer cell.

[25]  O. Elemento,et al.  Revealing global regulatory perturbations across human cancers. , 2009, Molecular cell.

[26]  R. Russell,et al.  Glioma stem cell lines expanded in adherent culture have tumor-specific phenotypes and are suitable for chemical and genetic screens. , 2009, Cell stem cell.

[27]  O. Filhol,et al.  Protein Kinase CK2 in Health and Disease , 2009, Cellular and Molecular Life Sciences.

[28]  Santosh Kesari,et al.  Malignant gliomas in adults. , 2008, The New England journal of medicine.

[29]  N. Slonim,et al.  A universal framework for regulatory element discovery across all genomes and data types. , 2007, Molecular cell.

[30]  J. Hiscott.  Triggering the Innate Antiviral Response through IRF-3 Activation* , 2007, Journal of Biological Chemistry.

[31]  A Heerschap,et al.  Development of luciferase tagged brain tumour models in mice for chemotherapy intervention studies. , 2006, European journal of cancer.

[32]  Koji Yoshimoto,et al.  Primary Glioblastomas Express Mesenchymal Stem-Like Properties , 2006, Molecular Cancer Research.

[33]  Thomas D. Wu,et al.  Molecular subclasses of high-grade glioma predict prognosis, delineate a pattern of disease progression, and resemble stages in neurogenesis. , 2006, Cancer cell.

[34]  P. Kleihues,et al.  Population-based studies on incidence, survival rates, and genetic alterations in astrocytic and oligodendroglial gliomas. , 2005, Journal of neuropathology and experimental neurology.

[35]  S. Horvath,et al.  Gene Expression Profiling of Gliomas Strongly Predicts Survival , 2004, Cancer Research.

[36]  Daniel J Brat,et al.  Microregional extracellular matrix heterogeneity in brain modulates glioma cell invasion. , 2004, The international journal of biochemistry & cell biology.

[37]  T. Taniguchi,et al.  The IRF family transcription factors at the interface of innate and adaptive immune responses. , 2013, Cold Spring Harbor symposia on quantitative biology.

[38]  A. Jemal,et al.  Global cancer statistics , 2011, CA: a cancer journal for clinicians.

[39]  L. Shaw.  Tumor cell invasion assays. , 2005, Methods in molecular biology.